L
Laurence Meyer
Researcher at French Institute of Health and Medical Research
Publications - 188
Citations - 6667
Laurence Meyer is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Viral load & Population. The author has an hindex of 43, co-authored 172 publications receiving 5660 citations. Previous affiliations of Laurence Meyer include University of Paris-Sud & Université Paris-Saclay.
Papers
More filters
Journal ArticleDOI
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
Jean-Michel Molina,Jean-Michel Molina,Isabelle Charreau,Bruno Spire,Laurent Cotte,Julie Chas,Catherine Capitant,Cécile Tremblay,Daniela Rojas-Castro,Eric Cua,Armelle Pasquet,Camille Bernaud,Claire Pintado,Constance Delaugerre,Constance Delaugerre,Luis Sagaon-Teyssier,Soizic Le Mestre,Christian Chidiac,Gilles Pialoux,Diane Ponscarme,Julien Fonsart,David Thompson,Mark A. Wainberg,Véronique Doré,Laurence Meyer,Laurence Meyer,Laurence Meyer,C Capitant,I Charreau,Emmanuelle Netzer,N Leturque,J Binesse,V. Foubert,M Saouzanet,F Euphrasie,Diane Carette,B Guillon,Y Saïdi,J P Aboulker,B Spire,M Suzan,G Cattin,Baptiste Demoulin,L Sagaon-Teyssier,Nicolas Lorente,V Doré,E Choucair,S Le Mestre,A Mennecier,N. Etien,M C Simon,A Diallo,S Gibowski,Jean-François Delfraissy,D Thompson,Jacquie Sas,J Pankovitch,Marina B. Klein,A Anis,Benoit Trottier,Jean-Guy Baril,Antoine Chéret,Michel Besnier,W. Rozenbaum,Nathalie Bajos,Julie Timsit,Gilles Peytavin,Isabelle Durand-Zaleski,Jean-Pierre Aboulker,Marie Suzan-Monti,Gabriel Girard,Daniela Rojas Castro,Marie Préau,Michel Morin,Anaïs Mennecier,Elias Choucair,Marie-Christine Simon,Joanne Otis,Alpha Diallo,Séverine Gibowski,Cecile Rabian +80 more
TL;DR: On-demand oral PrEP is highly effective at preventing HIV infection among high-risk men who have sex with men and therefore represents an alternative to daily PrEP, expanding choices for HIV prevention.
Journal ArticleDOI
Genomewide Association Study of an AIDS-Nonprogression Cohort Emphasizes the Role Played by HLA Genes (ANRS Genomewide Association Study 02)
Sophie Limou,Sigrid Le Clerc,Sigrid Le Clerc,Cédric Coulonges,Cédric Coulonges,Wassila Carpentier,Christian Dina,Olivier Delaneau,Taoufik Labib,Lieng Taing,Robert Sladek,Christiane Deveau,Rojo Ratsimandresy,Matthieu Montes,Jean Louis Spadoni,Jean-Daniel Lelièvre,Yves Levy,Amu Therwath,François Schächter,Fumihiko Matsuda,Ivo Gut,Philippe Froguel,Philippe Froguel,Jean François Delfraissy,Serge Hercberg,Jean-François Zagury,Jean-François Zagury,Laurence Meyer,Philippe Broët,Cyril Dalmasso,Patrice Debré,Ioannis Theodorou,Christine Rouzioux +32 more
TL;DR: The present study underscores the potential for some HLA genes to control disease progression soon after infection, and confirms an independent role for ZNRD1 in the HLA locus.
Journal ArticleDOI
Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines
Sara Lodi,Andrew N. Phillips,Giota Touloumi,Ronald B. Geskus,Laurence Meyer,Rodolphe Thiébaut,Nikos Pantazis,Julia del Amo,Anne M Johnson,Abdel Babiker,Kholoud Porter +10 more
TL;DR: Mixed models predict substantial increases in the number of individuals who require treatment and call for early HIV testing, and predicted time between seroconversion and CD4+ cell count <200, <350, and <500 cells/mm³ as well as CD4- cell count distribution and proportions reaching these thresholds at 1, 2, and 5 years after serconversion.
Journal ArticleDOI
Early Levels of HIV-1 DNA in Peripheral Blood Mononuclear Cells Are Predictive of Disease Progression Independently of HIV-1 RNA Levels and CD4+ T Cell Counts
Christine Rouzioux,Jean-Baptiste Hubert,Marianne Burgard,Christiane Deveau,Cécile Goujard,Marc Bary,Daniel Sereni,Jean-Paul Viard,Jean-François Delfraissy,Laurence Meyer +9 more
TL;DR: The results suggest that HIV DNA level could be a useful additional marker in clinical practice and could aid in helping to define the best time to initiate treatment for each patient.
Journal ArticleDOI
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE
James B. Young,Mina Psichogiou,Laurence Meyer,Sylvie Ayayi,Sophie Grabar,François Raffi,Peter Reiss,Brian Gazzard,Mike Sharland,Félix Gutiérrez,Niels Obel,Ole Kirk,José M. Miró,Hansjakob Furrer,Antonella Castagna,Stéphane De Wit,Josefa Muñoz,Jesper Kjaer,Jesper Grarup,Geneviève Chêne,Heiner C. Bucher +20 more
TL;DR: Using data from the Collaboration of Observational HIV Epidemiological Research Europe, Jim Young and colleagues show that in successfully treated patients the risk of a new AIDS event or death follows a CD4 cell count gradient in patients with viral suppression.